Cervagem/Dilapan for preoperative XXXX prior to vacuum aspiration for termination of first trimester pregnancy. A prospective randomized study.

@entity1 @entity384 @entity282 @entity190
The present study included 40 healthy nulliparous @entity1 admitted to the hospital for termination of first trimester pregnancy. The @entity1 were randomly allocated to two study groups. One group was treated for 4 hours with one 1 mg Cervagem vaginal suppository prior to vacuum aspiration, the other was treated 4 hours with a Dilapan osmotic dilator intracervically. The @entity1 were continuously supervised during treatment and after operation. Side effects and analgesic consumption were recorded. At operation the degree of @entity384 , @entity190 was registered. Dilapan was more effective and more uniform in dilating the cervix (p less than 0.05) and eventual further dilatation was easier (p less than 0.05). The @entity190 was higher in the Dilapan-treated group (p less than 0.05). Side effects of @entity282 and use of analgesic injections were higher in the Cervagem group (p less than 0.05). It is concluded that both methods are effective in dilating the cervix prior to vacuum aspiration, with Dilapan being the more effective dilator with the lower frequency of side effects.
